A PMHNP practicing via telehealth is evaluating a new patient who relocated to a different state. The patient has been stable on amphetamine salts 20 mg daily for ADHD and alprazolam 0.5 mg PRN for panic disorder, both prescribed by his previous psychiatrist. The patient requests continuation of both medications via telehealth. The PMHNP must navigate the regulatory framework for prescribing controlled substances through telehealth across state lines.